Disseminated intravascular coagulation Dr. S. Parthasarathy MD., DA., DNB, MD (Acu), Dip. Diab. DCA, Dip. Software statistics, PhD(physiology) Mahatma.

Slides:



Advertisements
Similar presentations
Chapter 12 Disorders of Hemostasis
Advertisements

Disseminated Intravascular Coagulation Robert R. Zaid D.O. Genesys Regional Medical Center PGY-I.
An Overview of Hemostasis
Disseminated Intravascular Coagulation
 An acquired syndrome characterized by systemic intravascular coagulation  Coagulation is always the initial event.  Most morbidity and mortality depends.
Initiation substances activate s by proteolysis a cascade of circulating precursor proteins which leads to the generation of thrombin which in turn converts.
Basic Principles of Hemostasis
Haemostasis Tiffany Shaw MBChB II Haemostasis Pathway Injury Collagen exposure Tissue Factor Platelet adhesion Coagulation Cascade Release reaction.
Blood Clotting Robin Gray.
Vascular Pharmacology
Gatmaitan, Raymond Vincent Golpeo, Kirsten C.
Pathology of Coagulation I- Deficiency of Coagulation Factors II- II- HYPERCOAGULABLE STATES.
D - DEATH I - IS C - COMING DIC is an important contributor to maternal mortality and morbidity.
Bleeding time,clotting time, PT, and PTT
1 Disseminated Intravascular Coagulation Paramedic Program Chemeketa Community College.
Disseminated intravascular coagulation (DIC)
Dr msaiem Acquired Coagulation Disorders Dr Mohammed Saiem Al-dahr KAAU Faculty of Applied Medical Sciences.
Asilmi HEMOSTASIS Ahmad Shihada Silmi Faculty of Sciences IUG Med. Tech. Dep. Room # B326.
Week 7: Fibrinolysis and Thrombophilia Secondary fibrinolysis Secondary fibrinolysis Primary fibrinolysis Primary fibrinolysis Plasminogen Plasminogen.
Drmsaiem FIBRINOLSIS SYSTEM DR MOHAMMED SAIEMALDAHR Faculty of Applied Medical Sciences Medical Technology Dep.
Dr MOHAMMED H SAIEMALDAHR FACULTY of Applied Medical Sciences
Lecture NO- 12- Dr: Dalia Kamal Eldien.  Coagulation: Is the process by which blood changes from a liquid to a clot. Coagulation begins after an injury.
DIC Disseminated intravascular coagulation
This lecture was conducted during the Nephrology Unit Grand Ground by a Sub-intern under Nephrology Division, Department of Medicine in King Saud University.
Tabuk University Faculty of Applied Medical Sciences Department Of Medical Lab. Technology 3 rd Year – Level 5 – AY
Hemostasis and Blood Coagulation
Dr Mahvash Khan MBBS, MPhil. ◦ Occurs inside the blood vessels, it is also called fibrinolysis ◦ Occurs due to a substance known as plasmin (fibrinolysin)
Scheme of Coagulation F XIIF XIIa F XIF XIa F IX F X F IXa F VIIaF VII Extrinsic System Tissue damage Release of tissue thromboplastine (F III) Intrinsic.
1 HAEMOSTASIS. 2 Definition Haemostasis is a complex sequence of physical and biochemical changes induced by damage to tissues and blood vessels, which.
Disseminated intravascular coagulation
Coagulation Concepts A review of hemostasis Answers are in the notes pages.
MLAB 1227: Coagulation Keri Brophy-Martinez Coagulation Disorders: Secondary Hemostasis Part Two.
DIC disseminated intravascular coagulation DIC is characterized by widespread coagulation and bleeding in the vascular compartment. DIC begins with massive.
Disseminated Intravascular Coagulation (DIC) 【 Change of basic pathology 】 【 Change of basic pathology 】 Key change Key change This fine homeostatic.
Coagulation Mechanisms
Disseminated Intravascular Coagulation. XIIa Coagulation cascade IIa Intrinsic system (surface contact ) XII XI XIa Tissue factor IX IXa VIIa VII VIIIVIIIa.
The Clotting Cascade and DIC Karim Rafaat, MD. Coagulation Coagulation is a host defense system that maintains the integrity of the high pressure closed.
Investigation of Haemostasis MS. c. program Lab-9.
Fibrinolysis and Hyperfibrinolysis TEG Analysis
Hematology Blueprint PANCE Blueprint. Coagulation Disorders.
DIC. acute, subacute or chronic widespread intravascular fibrin formation in response to excessive blood protease activity that overcomes the natural.
Coagulation Disorders and Disseminated Intravascular Coagulation (DIC)
MLAB Coagulation Keri Brophy-Martinez Fibrinolytic System.
Hemostasis and Coagulation Hemostasis Hemostasis is the maintenance of circulating blood in the liquid state and retention of blood in the vascular system.
Haemostasis. Indications for hemostasis test – Identify patients presenting with bleeding that have a correctable bleeding tendency – Identify patients.
1. Normal haemostasis Haemostasis is the process whereby haemorrhage following vascular injury is arrested. It depends on closely linked interaction.
Hemostasis Is a complex process which causes the bleeding process to stop. It refers to the process of keeping blood within a damaged blood vessel. Dependent.
Approach to the Bleeding Child. Evaluation  History Current Bleeding Medical Family  Physical exam  Selected laboratory investigations.
Management Control or elimination of the underlying cause Severe DIC: – Control of hemodynamic parameters – Respiratory support – Surgery Attempts to treat.
Plasma and plasma components in the management of disseminated intravascular coagulation Marcel Levi* Academic Medical Center, University of Amsterdam,
Bleeding Tendency Dr. Mervat Khorshied Ass. Prof. of Clinical and Chemical Pathology.
Platelets. Fig Hemostasis the process by which the bleeding is stopped from broken vessels. steps involved: Vascular spasm. Platelets plug formation.
Obada Al-Eisa Saud Bashtawy Emad Mansour.  It is an acquired condition characterized by massive activation of the coagulation system.  It is always.
IN THE NAME OF GOD Disseminated Intravascular Coagulation Dr.h-kayalhaAnesthesiologist.
Recent advances- Novoseven
Activation of the Hemostatic System During Cardiopulmonary Bypass
Activation of the Hemostatic System During Cardiopulmonary Bypass
General Principles of Hemostasis Kristine Krafts, M.D.
Bleeding disorders Dr. Feras FARARJEH.
Constituents of the blood: Platelets and plasma
Hemodynamic disorders (1 of 3)
and anti-thrombotic pharmocology Tom Williams
The Hematologic System as a Marker of Organ Dysfunction in Sepsis
Disseminated intravascular coagulation (DIC) + Thrombotic microangiopathies (TTP+HUS) Ali Al Khader, M.D. Faculty of Medicine Al-Balqa’ Applied University.
Disseminated Intravascular Coagulation
Bleeding disorders Dr. Feras FARARJEH.
Disseminated intravascular coagulation (DIC)
General Principles of Hemostasis Kristine Krafts, M.D.
Drugs Affecting Blood.
Presentation transcript:

Disseminated intravascular coagulation Dr. S. Parthasarathy MD., DA., DNB, MD (Acu), Dip. Diab. DCA, Dip. Software statistics, PhD(physiology) Mahatma Gandhi Medical College and Research Institute, Puducherry, India

Definition Disseminated intravascular coagulation (DIC) is a clinicopathologic syndrome in which widespread intravascular coagulation is induced by procoagulants that are introduced into or produced in the blood secondary to 1 or more underlying condition(s)

Normal hemostasis

The process -- stage 1 Injury → platelet adhere (vWF), subsequent platelet activation and aggregation (vWf, serotonin, ADP) ↓ The platelet glycoprotein (Gp) IIb/IIIa ( IIb3 ) complex occlusive platelet thrombus. (plug)

The process – stage 2 Plasma coagulation proteins (clotting factors) normally circulate in plasma in their inactive forms extrinsic and intrinsic pathways – Active forms Endothelial tissue factor + platelet factors Clotting – fibrin plug ( THROMBUS )

Stage 3 Fibrinolytics

Platelet plug Fibrin clot Fibrinolysis +anticoagulation

Back to DIC

DIC never occurs alone DIC is presently recognized as a deviation from the normal physiologic balance between the processes of thrombus formation and fibrinolysis.

Types as clinical - earlier described Acute- Large material, overwhelming process Bad Chronic – slow process – body compensates

Incidence 1.5 % of in hospital patients 25 % of trauma 30 % of sepsis patients Not uncommon

Causes Infection Trauma Malignancy Obstetrics Toxic Burns Pancreatitis obstructive jaundice

The basis excessive generation and circulation of thrombin impairment of the natural anticoagulant pathway suppression of fibrinolysis

Pathogenesis Malignant cells, sepsis, crush injuries Tissue factor activated TF + Factor VII Activated factor IX and X Thrombin

OK – now thrombin formed There are a lot of natural anticoagulants Should there be a problem ??

There are 3 most common Anticoagulants in the body: – Antithrombin, – Active Protein C – Tissue factor pathway inhibitor (TFPI). In DIC: – ↓Antithrombin – ↓Active Protein C

Anticoagulation NormalDIC

Cascade continues

Fibrinolysis Fibrinolysis is a process in which plasmin, an active form of plasminogen, cleaves fibrin and fibrinogen to restore vessel patency following hemostasis Fibrin to FDPs √

Process proceeds -----

Malignancy – tissue factor Sepsis – inflammatory cytokines

How does it present ?? Leukemia, obs Sepsis Sepsis Obs, bleeding Pre DIC

What is common ?? Acute --- bleeding manifestations Chronic --- thrombotic manifestations Setting of a DIC !! Sepsis – acute Malignancy– chronic

Bleeding Bleeding is a more common clinical presentation in patients with acute, fulminant DIC. Petechiae, ecchymoses, epistaxis, gingival/ mucosal bleeding, hematuria, and bleeding from wounds and puncture sites

Thrombosis- organs affected and symptoms More chances Brain Heart Kidney Less chances Adrenals Spleen Lungs Liver

Lab diagnosis Thrombocytopenia is the hallmark of DIC, and its presence should prompt consideration of DIC. (platelet count <50 · 10 9 /l) A low platelet count on initial testing and, in particular, a progressive drop in the platelet count are sensitive signs of DIC Thrombin induced platelet aggregation Schistocytes on peripheral smear

Lab diagnosis FDP consists of both fibrin and fibrin degradation products. Elevated levels of FDP reflect accelerated fibrinolysis due to plasmin and are found in 85% to 100% of patients with DIC OC pills, infarction, renal diseases ?? Test validity ?? Soluble fibrin monomer (SF) measurements offer theoretical advantages in DIC

Lab diagnosis D-dimer levels are elevated in almost all cases of DIC, but it may be falsely high in infection, inflammation, pregnancy, and other conditions involving thrombosis. PT is prolonged in 50% to 75% of DIC cases aPTT is prolonged in 50% to 60% of patients Fibrinogen level is low 100– both PT and apTT prolonged – acute phase reactant !!

Exclude heparin contamination

Diagnosis – in order !! Platelets ↓ FDPs - ↑ Prothrombin time ↓ aPTT ↓ Fibrinogen ↓ In a setting

D dimer with fragmented red cells in a peripheral film In a chronic setting Normal PT and apTT May suggest DIC

TEG abnormal in septic patients, their diagnostic sensitivity/specificity for DIC is unclear atypical light transmittance profile on the aPTT has been associated with DIC- biphasic wave forms

A lot of such scores like that

DIC is dynamic

Management

1.Treatment of the cause 2.Blood component therapy – stop the cycle 3. Anticoagulation

1.Treatment of the cause Sepsis OBG Trauma Malignancy?

Blood – Recommended in bleeding type of DIC

No role for prophylaxis

Anticoagulation There is no strong evidence to support the use of heparin in DIC Shows a worse outcome in DIC patients who are treated with heparin. Despite this controversy, it is commonly accepted to use heparin in cases where thrombosis seems to predominate (eg, purpura fulminans, solid tumors, hemangiomas, dead fetus syndrome). 5 units / kg /hour ??

Presently, with the exception of Trousseau syndrome (occurrence of thrombophlebitis migrans with visceral cancer), anticoagulation is not recommended as a treatment for DIC.

Anticoagulation successful use of recombinant factor VIIa in patients with DIC and life-threatening bleeding. However, the efficacy and safety of this treatment in DIC is unknown Antithrombin concentrate – labs better but patients ??

Anticoagulation Consider treating patients with severe sepsis and DIC with recombinant human activated protein C (continuous infusion, 24 mic.g/kg/h for 4 d) Risk of bleeds Aptt prolonged

Others Synthetic protease inhibitors, such as Gabexate mesilate®and nafamostat®, exhibit multiple- functions, including antagonistic effects on the kinin/kallikrein system, fibrinolysis, complement system, and coagulation system.

Tx – no role Patients with DIC that is characterized by a primary hyperfibrinolytic state and who present with severe bleeding could be treated with lysine analogues, such as tranexamic acid (e.g. 1 g every 8 h) Possible promyelocytic leukemia

Comes for surgery Perioperative goals include maintaining the platelet count in the range of 25,000– 50,000/μL and the fibrinogen level greater than 50 mg/dL.

Summary What is DIC ?? Causes Clinical features Lab diagnosis Treatment

What does DIC mean DIC = “Death is Coming